AVITA Medical, Inc. (RCEL)
USD 7.35
(-2.2%)
USD 7.35
(-2.2%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 144.33 Million USD | 0.0% |
| 2020 | 82.46 Million USD | -30.99% |
| 2019 | 119.48 Million USD | 0.0% |
| 2017 | 23 Million USD | 199.97% |
| 2016 | 7.66 Million USD | -10.87% |
| 2015 | 8.6 Million USD | 58.05% |
| 2014 | 5.44 Million USD | -25.57% |
| 2013 | 7.31 Million USD | -43.35% |
| 2012 | 12.9 Million USD | 20.57% |
| 2011 | 10.7 Million USD | -42.72% |
| 2010 | 18.68 Million USD | 137.91% |
| 2009 | 7.85 Million USD | -0.97% |
| 2008 | 7.93 Million USD | -48.84% |
| 2007 | 15.5 Million USD | 28.75% |
| 2006 | 12.04 Million USD | -7.91% |
| 2005 | 13.07 Million USD | 0.0% |
| 2003 | 9.16 Million USD | 7.12% |
| 2002 | 8.55 Million USD | 69.23% |
| 2001 | 5.05 Million USD | -6.64% |
| 2000 | 5.41 Million USD | 93.11% |
| 1999 | 2.8 Million USD | 149.63% |
| 1998 | 1.12 Million USD | -37.47% |
| 1997 | 1.79 Million USD | -64.25% |
| 1996 | 5.02 Million USD | 10.07% |
| 1995 | 4.56 Million USD | -24.59% |
| 1994 | 6.05 Million USD | -12.57% |
| 1993 | 6.92 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q3 | 126.02 Million USD | -2.77% |
| 2023 Q2 | 129.61 Million USD | -6.44% |
| 2023 Q1 | 138.54 Million USD | -4.02% |
| 2022 Q2 | 148.7 Million USD | 4.5% |
| 2022 Q3 | 156.24 Million USD | 5.07% |
| 2022 FY | 144.33 Million USD | 0.0% |
| 2022 Q4 | 144.33 Million USD | -7.62% |
| 2022 Q1 | 142.3 Million USD | 0.0% |
| 2021 Q3 | 121.17 Million USD | -3.45% |
| 2021 Q1 | 168.62 Million USD | 87.6% |
| 2021 Q2 | 125.5 Million USD | -25.57% |
| 2020 Q4 | 89.88 Million USD | -14.67% |
| 2020 FY | 82.46 Million USD | -30.99% |
| 2020 Q2 | 119.48 Million USD | 0.0% |
| 2020 Q3 | 105.34 Million USD | -11.84% |
| 2019 FY | 119.48 Million USD | 0.0% |
| 2019 Q2 | 36.72 Million USD | 0.0% |
| 2019 Q4 | 136.25 Million USD | 0.0% |
| 2018 Q2 | 23 Million USD | 0.0% |
| 2018 Q4 | 36.34 Million USD | 0.0% |
| 2017 Q4 | 16.51 Million USD | 0.0% |
| 2017 Q2 | 7.66 Million USD | 0.0% |
| 2017 FY | 23 Million USD | 199.97% |
| 2016 Q2 | 8.6 Million USD | 0.0% |
| 2016 Q4 | 11.84 Million USD | 0.0% |
| 2016 FY | 7.66 Million USD | -10.87% |
| 2015 FY | 8.6 Million USD | 58.05% |
| 2015 Q2 | 5.44 Million USD | 0.0% |
| 2015 Q4 | 10.52 Million USD | 0.0% |
| 2014 Q2 | 7.31 Million USD | 0.0% |
| 2014 Q4 | 3.6 Million USD | 0.0% |
| 2014 FY | 5.44 Million USD | -25.57% |
| 2013 FY | 7.31 Million USD | -43.35% |
| 2013 Q4 | 8.86 Million USD | 0.0% |
| 2013 Q2 | 12.9 Million USD | 0.0% |
| 2012 Q2 | 10.7 Million USD | 0.0% |
| 2012 FY | 12.9 Million USD | 20.57% |
| 2012 Q4 | 16.15 Million USD | 0.0% |
| 2011 FY | 10.7 Million USD | -42.72% |
| 2011 Q2 | 18.68 Million USD | 0.0% |
| 2011 Q4 | 15.68 Million USD | 0.0% |
| 2010 FY | 18.68 Million USD | 137.91% |
| 2010 Q2 | 7.85 Million USD | 0.0% |
| 2010 Q4 | 8.02 Million USD | 0.0% |
| 2009 Q4 | 8.9 Million USD | 0.0% |
| 2009 FY | 7.85 Million USD | -0.97% |
| 2009 Q2 | 7.93 Million USD | 0.0% |
| 2008 Q4 | 8.88 Million USD | 0.0% |
| 2008 Q2 | 15.5 Million USD | 0.0% |
| 2008 FY | 7.93 Million USD | -48.84% |
| 2007 Q4 | 10.86 Million USD | 0.0% |
| 2007 Q2 | 12.04 Million USD | 0.0% |
| 2007 FY | 15.5 Million USD | 28.75% |
| 2006 FY | 12.04 Million USD | -7.91% |
| 2006 Q2 | 13.07 Million USD | 0.0% |
| 2006 Q4 | 18.88 Million USD | 0.0% |
| 2005 Q4 | 16.41 Million USD | 0.0% |
| 2005 FY | 13.07 Million USD | 0.0% |
| 2004 Q2 | 9.16 Million USD | 0.0% |
| 2004 Q4 | 18.17 Million USD | 0.0% |
| 2003 Q4 | 12.87 Million USD | 0.0% |
| 2003 FY | 9.16 Million USD | 7.12% |
| 2002 Q4 | 8.55 Million USD | 0.0% |
| 2002 FY | 8.55 Million USD | 69.23% |
| 2001 Q4 | 5.05 Million USD | 0.0% |
| 2001 FY | 5.05 Million USD | -6.64% |
| 2000 Q4 | 5.41 Million USD | 0.0% |
| 2000 FY | 5.41 Million USD | 93.11% |
| 1999 Q4 | 2.8 Million USD | 0.0% |
| 1999 FY | 2.8 Million USD | 149.63% |
| 1998 Q4 | 1.12 Million USD | 0.0% |
| 1998 FY | 1.12 Million USD | -37.47% |
| 1997 FY | 1.79 Million USD | -64.25% |
| 1997 Q4 | 1.79 Million USD | 0.0% |
| 1996 FY | 5.02 Million USD | 10.07% |
| 1995 FY | 4.56 Million USD | -24.59% |
| 1994 FY | 6.05 Million USD | -12.57% |
| 1993 FY | 6.92 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -360.18% |
| BrainsWay Ltd. | 62.97 Million USD | -129.213% |
| Cerus Corporation | 197.74 Million USD | 27.008% |
| Envoy Medical, Inc. | 7.64 Million USD | -1789.267% |
| electroCore, Inc. | 16.38 Million USD | -780.82% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -1776.495% |
| IceCure Medical Ltd | 16.41 Million USD | -779.586% |
| Inogen, Inc. | 326.19 Million USD | 55.75% |
| OrthoPediatrics Corp. | 449.58 Million USD | 67.895% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -429.3% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -770.619% |
| MaxCyte, Inc. | 268.27 Million USD | 46.197% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -1682.566% |
| Nexalin Technology, Inc. | 3.63 Million USD | -3874.211% |
| Orthofix Medical Inc. | 925.31 Million USD | 84.401% |
| PAVmed Inc | 33.11 Million USD | -335.822% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -0.619% |
| RxSight, Inc. | 182.55 Million USD | 20.931% |
| Sight Sciences, Inc. | 166.65 Million USD | 13.388% |
| SI-BONE, Inc. | 230.42 Million USD | 37.359% |
| TELA Bio, Inc. | 78.04 Million USD | -84.937% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 42.701% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -1245.2% |
| Acutus Medical, Inc. | 53.96 Million USD | -167.494% |
| Talis Biomedical Corporation | 98.34 Million USD | -46.776% |
| Spectral AI, Inc. | 10.69 Million USD | -1249.981% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 33.985% |
| CVRx, Inc. | 115.22 Million USD | -25.264% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -146.058% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -4533.331% |
| Bioventus Inc. | 810.91 Million USD | 82.2% |
| Venus Concept Inc. | 93.65 Million USD | -54.12% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -461.088% |
| LivaNova PLC | 2.42 Billion USD | 94.059% |
| 908 Devices Inc. | 202.98 Million USD | 28.89% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 82.074% |
| Nemaura Medical Inc. | 14.56 Million USD | -891.126% |
| NeuroPace, Inc. | 107.65 Million USD | -34.081% |
| LENSAR, Inc. | 69.58 Million USD | -107.43% |
| Apyx Medical Corporation | 79.24 Million USD | -82.155% |
| Cutera, Inc. | 346.29 Million USD | 58.318% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -243.536% |
| BioSig Technologies, Inc. | 1.79 Million USD | -7927.808% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 46.666% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -238.342% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 96.183% |
| Axonics, Inc. | 719.92 Million USD | 79.951% |
| Outset Medical, Inc. | 313.8 Million USD | 54.003% |
| IRIDEX Corporation | 34.43 Million USD | -319.154% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 64.336% |
| IRadimed Corporation | 92.15 Million USD | -56.626% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -2647.24% |
| INVO Bioscience, Inc. | 20.88 Million USD | -591.026% |
| Telesis Bio, Inc. | 70.41 Million USD | -104.996% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 6.335% |
| Varex Imaging Corporation | 1.24 Billion USD | 88.449% |
| Quipt Home Medical Corp. | 247.4 Million USD | 41.659% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -1450.376% |
| Pulmonx Corporation | 178.95 Million USD | 19.341% |
| Dynatronics Corporation | 25.94 Million USD | -456.426% |
| Modular Medical, Inc. | 13.8 Million USD | -945.412% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -1245.576% |
| Semler Scientific, Inc. | 78.06 Million USD | -84.897% |
| InMode Ltd. | 863.28 Million USD | 83.28% |
| Bruker Corporation | 4.24 Billion USD | 96.604% |
| Cytosorbents Corporation | 53.26 Million USD | -171.007% |
| DexCom, Inc. | 6.26 Billion USD | 97.696% |
| Align Technology, Inc. | 6.08 Billion USD | 97.627% |
| Viveve Medical, Inc. | 25.91 Million USD | -457.018% |
| ZimVie Inc. | 1.2 Billion USD | 88.025% |
| Movano Inc. | 9.42 Million USD | -1432.109% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 70.997% |
| Nexalin Technology, Inc. | 3.63 Million USD | -3874.211% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -146.058% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 84.849% |
| Profound Medical Corp. | 43.68 Million USD | -230.401% |
| Insulet Corporation | 2.58 Billion USD | 94.423% |
| enVVeno Medical Corporation | 48.63 Million USD | -196.782% |
| Surmodics, Inc. | 185.73 Million USD | 22.286% |
| iCAD, Inc. | 41.41 Million USD | -248.496% |
| Nuwellis, Inc. | 9.77 Million USD | -1377.38% |
| Biotricity, Inc. | 5.94 Million USD | -2328.893% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 66.676% |
| Aethlon Medical, Inc. | 8.24 Million USD | -1650.428% |
| InspireMD, Inc. | 47.64 Million USD | -202.962% |
| PAVmed Inc. | 33.11 Million USD | -335.822% |
| BIOLASE, Inc. | 35.1 Million USD | -311.213% |
| Beyond Air, Inc. | 56.96 Million USD | -153.401% |
| FONAR Corporation | 214.24 Million USD | 32.629% |
| AxoGen, Inc. | 196.82 Million USD | 26.667% |
| Vivani Medical, Inc. | 45.79 Million USD | -215.173% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 48.713% |
| Inari Medical, Inc. | 674.23 Million USD | 78.592% |
| UFP Technologies, Inc. | 404.13 Million USD | 64.284% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -516.875% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -1418.871% |
| Tenon Medical, Inc. | 6.34 Million USD | -2174.862% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -1434.389% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -39.26% |
| AdaptHealth Corp. | 4.61 Billion USD | 96.876% |
| Sintx Technologies, Inc. | 15.36 Million USD | -839.408% |
| NanoVibronix, Inc. | 6.67 Million USD | -2062.721% |
| Quanterix Corporation | 425.01 Million USD | 66.039% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -1450.376% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -168.654% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 91.733% |
| TransMedics Group, Inc. | 706.04 Million USD | 79.557% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -128.415% |
| NeuroMetrix, Inc. | 21.42 Million USD | -573.716% |
| Hyperfine, Inc. | 94.19 Million USD | -53.229% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 46.27% |
| Biomerica, Inc. | 9.25 Million USD | -1459.758% |
| Bone Biologics Corporation | 3.73 Million USD | -3761.668% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -2864.754% |
| Silk Road Medical, Inc | 265.3 Million USD | 45.596% |